Mini-hearts for disease modeling and drug testing - process optimization versus biological functionality.

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Tissue Engineering

Background:

• Traditional 2D cell cultures and animal models do not fully replicate human cardiac physiology.
• Existing 3D cardiac models lack the ability to pump fluid and relax, limiting their functional assessment.
• There is a critical need for human-based cardiac models that mimic native hemodynamics.

Purpose of the Study:

• To review the current state of engineered cardiac chambers.
• To highlight key design features and applications of these models.
• To discuss optimization strategies for enhanced biological fidelity and efficiency.

Main Methods:

• Review of current literature on engineered cardiac chambers.
• Analysis of design principles and modularity.
• Examination of applications in disease modeling and drug testing.

Main Results:

• Engineered cardiac chambers enable physiologically relevant pressure-volume measurements.
• These models capture both contractile and diastolic dynamics, mimicking native cardiac hemodynamics.
• Design principles focus on balancing biological fidelity with process efficiency.

Conclusions:

• Engineered cardiac chambers are a powerful platform for understanding cardiac disease mechanisms.
• These models offer significant potential to advance cardiovascular research and therapeutic development.
• Optimization through modular design is key for balancing biological relevance and practical application.